The prevalence of multiple sclerosis (MS) in northern and central Europe is known to be high-approximately 50-60 per 100 000-and it is believed to be low on the African continent (McAlpine et al., 1965 ).
In the islands of southern Europe, for example, in Sicily and Malta, placed between the areas of suspected high and low MS prevalence, important information could be found about the environmental and genetic factors responsible for the disease.
Although the environment appears to be of major causative importance, genetic factors are probably associated with susceptibility to the disease, as shown by the increased frequency of certain histocompatibility antigens (HLA-A3, B7, and DW2) in patients with MS (Lancet, 1976) . Genetic as well as environmental factors therefore need to be considered if any major differences in prevalence are found.
Among immigrants from Malta to England resident in Greater London and the West Midlands, no MS patients were admitted to hospital with the disease between 1960 and 1972, and 9-7 would have been the expected number if they had had the same admission rate as people born in the United Kingdom (Dean et al., 1976; 1977 
Results
After an intensive search, only 14 patients with probable MS (eight men and six women), and three with possible MS, could be found resident in the islands on the chosen prevalence day-1 January 1978, and no patients were found with retrobulbar neuritis only. Of the 14 with probable MS, 11 were living in Malta and three in Gozo. Fourteen probable MS patients out of a population of 322 600 is a crude prevalence of 4-3 per 100 000 (5.2 male and 3-6 female per 100 000). Age-standardised for the population of England and Wales, the rate in Malta would be 4-2 per 100 000.
Among the 14 probable MS patients in Malta, paraesthesia was the first symptom in six, paraplegia in three, retrobulbar neuritis in three, and diplopia in two. The average age on prevalence day was 34 9 years (35.9 for men and 33-5 for women). The average age at onset was 28-3. All the patients had at least partial remission. One patient was diagnosed as having Devic's syndrome. Nine of the 14 patients had also been investigated at a London teaching hospital, seven of the nine at the National Hospital, where the diagnosis of MS had been confirmed. Two of the three patients with possible MS had also been investigated at the National Hospital. The low prevalence of MS in Malta found in this study, 4-3 per 100 000, is in great contrast with the high prevalence in Enna city in Sicily, 53 per 100 000 (Dean et al., 1979 
1978.
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